Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Ig-Innovations
Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972
Contact Ig-Innovations
Website

 Latest Content from PMHub 

How Ease of Access to HES Data Benefits HCPs & Key NHS Stakeholders

White Papers and Resources | March 3, 2022 | Dice Medical Communications

Article written August 27th 2021

How a Copywriter Reads a Clinical Paper

White Papers and Resources | March 2, 2022 | Dice Medical Communications

What key elements you need to consider in a clinical paper (Article written November 18th 2021)

What does HCP engagement look like in a post-Covid world?

White Papers and Resources | March 2, 2022 | Dice Medical Communications

HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

Press Releases | March 2, 2022 | Lucid Group Communications Limited

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...

Nucleus Global launches new branding as it sets its sights on the future

Press Releases | March 1, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, has announced the launch of its new brand.With over 35 years of experience providing medical communications excellence to the...

White paper: Are we prepared for the influx of CAR-Ts?

White Papers and Resources | March 1, 2022 | Inizio

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

Shining a light on rare diseases with ‘Noah’s Story’

Press Releases | February 28, 2022 | Resonant Group

In recognition of Rare Disease Day, Bedrock share 4 minutes of a true story you won’t want to miss.

Accession welcomes Graham Ridgway as Non-Executive Chairman

Press Releases | February 25, 2022 | Accession

Accession, a specialist pharma market access consulting and software company, announces the appointment of accomplished software CEO Graham Ridgway as Non-Executive Chairman.

Rare Disease Day – looking to the future with hope

Press Releases | February 25, 2022 | Nucleus Global

On this year’s Rare Disease Day, Amanda Henkel, VP, Strategy, Nucleus X Consulting (part of Nucleus Global), reflects on recent advances in the rare disease setting.

Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women’s health

Press Releases | February 25, 2022 | Thrive Agency

Unequal health outcomes have been a reality for women throughout the world for far too long. But change is finally happening.